Antibody-drug conjugate (ADC): Providing clarity to complex cancer therapy development
3 October 2024
Break through with focused insight
Learn how Labcorp supported development of an ADC targeted chemotherapy and CDx enabling the sponsor to navigate therapy complexity, global trial design and patient selection for a breakthrough cancer treatment.
Latest content on antibody-drug conjugate (ADC)
Case study
Navigating complexities in ADC development with specialized global laboratory support and scientific expertise.
Brochure
Delivering global ADC development solutions
ADC
Your ADC journey begins with a vision—one where your drug candidate makes a profound impact on the lives of oncology patients.
Oncology
Your Partner in Precision Oncology Development